Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gold Mountain Signs Ore Purchase Agreement with New Gold

Gold Mountain Mining Corp. ( TSX-V: GMTN , Forum ) is pleased to announce it has signed an Ore Purchase Agreement with New Gold's New Afton Processing facility in Kamloops, BC. With this milestone, we are cash-flow ready once the necessary permits are approved. For...
Stockhouse Editorial | January 27, 2021 |

Karuna Shares Jump 375% Higher on Phase 2 Acute Psychosis Treatment Trial Data

Shares of Karuna Therapeutics, which completed an IPO in July 2019, soared more than 375% higher today after the firm reported that its KarXT met primary endpoint in a phase 2 clinical trial of acute psychosis in patients with schizophrenia. This morning clinical-stag...
Streetwise Reports | November 19, 2019 |

Intra-Cellular Therapies Shares Rise 200% on FDA Approval of Adult Schizophrenia Drug

Shares of Intra-Cellular Therapies opened greater than 100% higher today after the company reported that the FDA approved its antipsychotic CAPLYTA® (lumateperone) drug for the treatment of schizophrenia in adults. This morning a biopharmaceutical company foc...
Streetwise Reports | December 27, 2019 |

XPhyto: Proof of Concept for Mescalin Synthesis

It’s become a much talked-about story on both sides of the Atlantic. XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTCQB: XPHYF) has earned considerable media coverage in recent months due to its expansion into the development of psychedelic d...
Marc Davis | June 9, 2021 |

Buzz on the Bullboards: Try not to get spooked by recent market performances

The TSX has moved higher despite recent volatility, which also saw a boost from earnings, which have so far been exceeding expectations, following signs of a slowdown in interest rate hikes.
Jonathon Brown | October 27, 2022 |

Varta, Rock Tech Lithium, Millennial Lithium - all signs point to growth

ON THE AUTHOR: Carsten Mainitz The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research. Most r...
Carsten Mainitz | March 23, 2021 |

Technical Analyst Sees Signs of Upside Breakout on Small-Cap Oil & Gas Firm

Technical analyst Clive Maund explains why he expects this company's shares to break out. BNK Petroleum Inc. (BKX:TSX; BNKPF:OTCQX) has put in a disappointing performance since we went for it about a month ago —it has refused to break out of its downtrend and has inst...
Streetwise Reports | March 14, 2019 |

Lannett Signs Exclusive U.S. Distribution Deal with Sinotherapeutics; Shares Up 40%

Shares of Lannett Co. are up 40% today after announcing that it secured rights to be the exclusive U.S. distributor of Sinotherapeutics' antifungal drug that is an AB-rated generic for Noxafil. This morning generic drug maker Lannett Company Inc. (LCI:NYSE.MKT) anno...
Streetwise Reports | August 29, 2019 |

Is the Fed Gearing Up for a New Round of Quantitative Easing? Here Are the Possible Signs

“This is not QE. In no sense is this QE.” That was Jerome Powell in early October, answering a reporter’s question on whether the Federal Reserve’s intervention in the overnight U.S. repo market constituted anoth...
Frank Holmes | December 11, 2019 |

Gold, USD and the Euro: the Signs Ahead

Brexit has become very likely due to result of the UK vote. But so what (gold- and currency-wise)? The uncertainty dropped significantly, and markets were able to sign a breath of relief (bearish for gold), but on the other hand Brexit itself increases the geopolitical turmoil...
Przemyslaw Radomski, CFA | December 19, 2019 |
1 2 3 4 5 6 7 8 9 10 ...